Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup

RA Sperling, CR Jack Jr, SE Black, MP Frosch… - Alzheimer's & …, 2011 - Elsevier
Amyloid imaging related abnormalities (ARIA) have now been reported in clinical trials with
multiple therapeutic avenues to lower amyloid-β burden in Alzheimer's disease (AD). In …
被引用次数：716 相关文章

Amyloid‐related imaging abnormalities in amyloid‐modifying therapeutic trials: Recommendations from the Alzheimer's Association Research Roundtable Workgroup

RA Sperling, CR Jack Jr, SE Black… - Alzheimer's & …, 2011 - Wiley Online Library
Amyloid imaging related abnormalities (ARIA) have now been reported in clinical trials with
multiple therapeutic avenues to lower amyloid‐β burden in Alzheimer's disease (AD). In …

[引用][C] Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer's Association Research Roundtable …

RA Sperling, CR Jack, SE Black, MP Frosch… - Alzheimer's & …, 2011 - cir.nii.ac.jp
Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations
from the Alzheimer’s Association Research Roundtable Workgroup | CiNii Research CiNii 国立 …

[引用][C] Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer's Association Research Roundtable …

RA Sperling, CR Jack, SE Black… - Alzheimers & …, 2011 - researchinformation.amsterdamumc …
Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials:
Recommendations from the Alzheimer's Association Research Roundtable Workgroup …
[HTML] nih.gov

[HTML][HTML] Amyloid Related Imaging Abnormalities (ARIA) in Amyloid Modifying Therapeutic Trials: Recommendations from the Alzheimer's Association Research …

RA Sperling, CR Jack, SE Black… - … & dementia: the …, 2011 - ncbi.nlm.nih.gov
Amyloid Related Imaging Abnormalities (ARIA) in Amyloid Modifying Therapeutic Trials:
Recommendations from the Alzheimer’s Association Research Roundtable Workgroup - PMC …

Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup.

RA Sperling, CR Jack Jr, SE Black… - … & Dementia: the …, 2011 - europepmc.org
Amyloid imaging related abnormalities (ARIA) have now been reported in clinical trials with
multiple therapeutic avenues to lower amyloid-β burden in Alzheimer's disease (AD). In …

Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup

RA Sperling, CR Jack Jr, SE Black… - … & dementia: the …, 2011 - pubmed.ncbi.nlm.nih.gov
Amyloid imaging related abnormalities (ARIA) have now been reported in clinical trials with
multiple therapeutic avenues to lower amyloid-β burden in Alzheimer's disease (AD). In …

Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer's Association Research Roundtable Workgroup

RA Sperling, CR Jack, SE Black… - Alzheimer's and …, 2011 - mayoclinic.elsevierpure.com
Amyloid imaging related abnormalities (ARIA) have now been reported in clinical trials with
multiple therapeutic avenues to lower amyloid-β burden in Alzheimer's disease (AD). In …
[PDF] academia.edu

[PDF][PDF] Amyloid Related Imaging Abnormalities (ARIA) in Amyloid Modifying Therapeutic Trials: Recommendations from the Alzheimer's Association Research …

RA Sperlinga, CR Jackb, SE Blackc, MP Froschd… - academia.edu
NIH Public Access Page 1 Amyloid Related Imaging Abnormalities (ARIA) in Amyloid
Modifying Therapeutic Trials: Recommendations from the Alzheimer’s Association Research …

Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer's Association Research Roundtable Workgroup

RA Sperling, CR Jack, SE Black, MP Frosch… - Alzheimer's & Dementia …, 2011 - infona.pl
Amyloid imaging related abnormalities (ARIA) have now been reported in clinical trials with
multiple therapeutic avenues to lower amyloid-β burden in Alzheimer's disease (AD). In …